Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Import Safety Legislation: Generic Firms Could Accept Fees, Not Delays

Mar 02 2009

• By M. Nielsen Hobbs

Related Content

GMP Warnings Split Between Brand, Generic Firms; Congress Watches FDA

Feb 23 2009

Globalization Bill Creates Fees For Generic Pre-approval Inspections

Feb 02 2009

Ranbaxy’s First-To-File ANDAs At Risk In FDA Data Integrity Probe

Mar 02 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window